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Abstract
The analysis of the expression of the a chain of the IL-2 receptor (CD25.TAC) on the surface of B
lineage cells In mouse bone marrow reveals that It Is a useful marker to distinguish pre-B-l from
pre-B-ll cells. CD25 Is not expressed on CD45R(B220)+ c-*/f+ CD43+ TdT+ X.+ cM~ slg- IgH
chain locus DJH-rearranged pre-B-l cells of mouse bone marrow. It Is expressed on large cycling
CD45R(B220)+ c-Wf- CD43+ TdT- Xg+ cM+ slg- and on small resting CO45R(B220)+ c-Wf CO43~
TdT~ \f- CM" slg- IgH chain locus VHDJH-rearranged pre-B-ll cells. Therefore, the transition
from pre-B-l to large pre-B-ll cells Is marked by the downregulatlon of c-ldt and terminal
deoxynucleotldyl transferase (TdT), and by the upregulatton of CD25. SCID, RAG-2T, pMT and X,T
mutant mice do have normal, If not elevated numbers of pre-B-l cells but lack all CD25+ pre-B-ll
cells in their bone marrow. The expression of a transgenlc H chain under control of the >tH chain
enhancer in RAG-2T bone marrow B lineage precursors allows the development of large and
small CD25+ pre-B-ll cells. The results suggest that the differentiation of pre-B-l to pre-B-ll cells
In mouse bone marrow requires the expression of /iH chains and surrogate L chains In
membranes, probably on the surface of precursor B cells.
Introduction
B cell development in mouse bone marrow has been dissected
into different stages of cycling, large and non-cycling, small cell
populations which differentially express a variety of cell surface
and intracellular markers. Furthermore these different cell
populations either proliferate on stromal cells in the presence of
IL-7, on IL-7 alone or not at all, and can or cannot populate B
cell lineage compartments in severe combined immunodeftcient
(SCID) mice. Osmond (1) defined earty, intermediate and late
pro-B cells, and large and small pre-B cells by the differential
expression of the common leukocyte antigen CD45R(B220) and
IgM on the surface, and by the expression of terminal deoxy-
nucteotidyl transferase (TdT) and /iH chain in the cytoplasm (c/i).
Measurements of the incidence, the size, proliferation capacity,
turnover and production rates of these precursor B cell
compartments complemented the analyses. Hardy era/. (2)
distinguished fractions A - F by the differential expression of cell
surface CD45R(B220), CD43, heat stable antigen, BP-1, IgM and
IgD. These subpopulations were further characterized by their
responsiveness to IL-7 and stromal cells in vitro, previously
defined as differential properties of precursor B cells by Nishikawa
et a/. (3,4). Furthermore, the DNA of these subpopulations was
analyzed by polymerase chain reactions (PCR) for the rearrange-
ment status of H and L chain genes. These analyses were
completed in a second publication (5) by reverse transcription
polymerase chain reaction (RT-PCR) analyses of the expression
levels of the genes encoding TdT, myosin-like light chain (6), Xs
and Vp^e (7,8), as well as RAG-1 and RAG-2 (9,10).
We have previously distinguished stromal cell/IL-7-reactive,
transplantable pre-B-l cells (11) which express c-kit (12) and
surrogate L chain on the surface (13), from pre-B-ll cells which
have lost the capacity for long-term proliferation on stromal cells
in the presence of IL-7 and which no longer express c-kit and
surrogate L chain on the surface. Approximately 20% of all
pre-B-ll cells are cycling, while the remaining cells are resting
and a very large proportion of them express c^ (14,15). A part
of the cycling pre-B-ll cells, but none of the resting pre-B-ll cells,
express surrogate L chain in the cytoplasm.
Mutant mice with defects in B lymphocyte development have
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been found [SCID/SCID (16)], or have been generated by
targeted disruption of the RAG-1 or the RAG-2 gene (17,18), the
transmembrane portion of the /JH chain gene (19) or the Xj gene
(20). Previous analyses have shown that all these mutant mice
have normal, if not elevated numbers of pre-B-l cells but contain
<2.5% of the normal number of pre-B-ll cells in their bone
marrow (18,19,21 -24). As a consequence of all these analyses,
two pathways of B cell development have been proposed (22,24).
The decisive point of transition into the major pathway of
development, defective in the mutant mice, is proposed to occur
at the boundary of pre-B-l to pre-B-ll cells.
In this paper we first analyze the pre-B-l and pre-B-ll cell
populations of normal bone marrow for the expression of the
markers used by Osmond, by Hardy et al. and by ourselves. We
then employ a monoclonal antibody specific for the a chain of
the mouse IL-2 receptor [CD25(TAC)] to distinguish pre-B-l cells
[which do not express CD25(TAC)] from large and small pre-B-ll
cells (all of which express it). Rnally, the analysis for CD25(TAC)
expression of B lineage cells in bone marrow of the mutant mice
shows that < 1 % of all precursors express CD25(TAC) and, thus,
defines the defect in B cell development in the four types of
mutants as an inability of precursors to undergo transition from
the pre-B-l to the large, cycling pre-B-ll compartment. The results
are discussed in view of possible rdes of surrogate L chains in
association either with a complex or early proteins or with pH
chains.
Methods
Mice
Female BALB/c, DBA/2J, C3H/HeJ, CBA/J and C57BI/6J mice
( 4 - 5 weeks old) were purchased from Biological Research
Laboratories (Fullinsdorf, Switzerland). CB17 SCID mice were
originally obtained from M. Bosma (Institute for Cancer Research,
Fox Chase, Philadelphia, PA), RAG-2T mice were originally
obtained from F. Alt (The Children's Hospital, Boston, MA), /tMT
mice were originally obtained from K. Rajewsky (Institute fur
Genetik, Cologne, Germany) and X5 T mice were bred in our
own facilities. Mice carrying the Sp6 /*H transgene (25) were
kindly provided by A. Iglesias (Max-Planck-lnstitCit fur Psychiatrie,
Martinsried, Germany). These transgenic mice were crossed with
RAG-2T mice. Mice expressing the pH transgene were then
backcrossed to RAG-2T mice to obtain homozygous RAG-2T
mice expressing a ?H transgene.
Antibodies
The FTTC-, phycoerythrin (PE)- and allophycocyanin-conjugated
mAb RA3 6B2 (antw:D45R,B220), the FITC- and bJotin-conjugated
mAb 7D4 [antt-CD25(TAC)] and the FITC-conjugated mAb 6C3
(anti-BP-1) were all obtained from Pharmingen (San Diego, CA).
The mAbs ACK, (antks-W/) (26), S7 (anti-CD43) (2) and LM34
(anti-Xfi) (13) were purified from culture supernatants on Protein
G-Sepharose columns (Pharmacia, Uppsala, Sweden) as
recommended by the supplier. Purified mAbs were conjugated
with FITC, PE or biotin according to standard protocols. FITC-
conjugated goat anti-mouse IgM was purchased from Southern
Biotechnology Associates (Birmingham, AL) and FITC-conjugated
goat anti-rabbit IgG was obtained from Jackson ImmunoResearch
Laboratories (Milan Analytica AG, La Roche, Switzerland). The
rabbit anti-mouse TdT antiserum was a kind gift of D. Mathis
(CNRS, I'lNSERM Institut de Chimie Biologique, Strasbourg,
France). Streptavidin - PE was obtained from Southern Bio-
technology Associates, streptavidin -Tri-Color was obtained from
Caltag (San Francisco, CA) and streptavidin-RED 613 was
obtained from Gibco BRL (Gaithersburg, MD).
Cell surface staining and flow cytometric analysis
Bone marrow cells were depleted of slgM+ B cells by the use
of sheep anti-mouse Ig-conjugated Dynabeads (Dynal AS,
Skeryen, Norway) as recommended by the supplier. Depletion
was tested by flow cytometric analysis and revealed always
< 1 % contamination of slgM+ B cells in the bone marrow
cell preparations.
Cell surface staining was performed as described (23). Cell
sorting was performed using the FACStar-plus (Becton-Dickinson,
Mountain view, CA). Gates for sorting were set by forward
and side scatter on either total, small or large nucleated
bone marrow cells.
Intracellular staining
For testing cj» and cXj protein expression cells were fixed
for 10 min in 4% paraformaldehyde in PBS on ice and then
permeabilized with 0.2% Tween-20 in PBS for 20 min at 37°C.
For detecting c^ expression, cells were then incubated with
FITC-conjugated goat anti-mouse IgM (Southern Biotechnology
Associates) while 0X5 expression was visualized by incubating
the cells first with biotin-conjugated LM34 followed by strept-
avidin - PE or streptavidin - Tri-Cokx. Stained cells were analyzed
by FACScan. For determining TdT expression cells were fixed
for 5 min on ice with 1%paraforrrakJehyde are! then permeabiBzed
with 70% methanol on ice for 30 min. Cells were then incubated
with rabbit anti-mouse TdT followed by incubation with
FITC-conjugated goat anti-rabbit IgG. Stained cells were
analyzed by FACScan.
Cell cycle analysis
Sorted bone marrow cells were fixed in 70% ethanol overnight
at 4°C. Fixed cells were treated with 0.5 mg/ml RNase
(Boehringer Mannheim, Mannheim, Germany) for 30 min at 37°C
and then with 0.5 mg/ml Pepsin (Sigma, St Louis, MO) for 15 min
at 37°C to prepare nuclei. Nuclei were subsequently incubated
with 10 nglm\ ethidium bromide in 0.1 M Tris (pH 8.0) contain-
ing 0.25% (w/v) BSA for 15 min at room temperature. DNA
content was analyzed using a FACScan instrument.
Results
Expression of c-kit, CD43 and CD25(TAC) by CD45R(B220)+
slgM~ B lineage precursors of normal and mutant mouse bone
marrow
Previously we have shown that pre-B-l cells which had DJH
rearranged IgH chain loci and which possess the long-term
capacity to proliferate on stromal cells in the presence of IL-7
express CD45R(B220), c-kit and CD43, but not CD25 on their
surface (27). Upon in vitro differentiation of these pre-B-l cells
into more mature B cells by omission of IL-7 they lose c-kit and
CD43 expression but gain the expression of CD25 on the surface.
Therefore, CD25 might be a useful marker to distinguish DJH
CD25 (TAC) expression on pre-B cells . 1259
rearranged pre-B-l cells from VHDJH rearranged pre-B-ll cells.
Here we analyzed the expression of c-kit, CD43 and CD25
on the surface of CD45R(B220)+ slgM- B lineage precursors
of normal and mutant mouse bone marrow. In Fig. 1 the two-
color FACS analysis of bone marrow depleted of slgM+ B cells
of 4 - 5 week old BALB/c mice is shown. For the CD45R(B220)/
c-kit and the CD45R(B220)/CD43 expression all nucleated bone
marrow cells were analyzed, while CD45R(B220)/CD25 expres-
sion was analyzed on large cells (Fig. 1C, see inset) and on small
cells (Fig. 1D, see inset). Table 1 summarizes the quantitation
of these analyses in five normal inbred strains of mice and five
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Fig. 1 . Dual labeling analysts of slgM depleted bone marrow cells of
4 week old BALB/c mice for CD45R(B220)/c-*/r (A), CO45R(B220)/CD43
(B) and CD45R(B220)/CD25{TAC) (C and D). For the expression of
CD45R{B220)/c-Wf and CD45R{B220yCD43, total nucleated bone marrow
cells were analyzed while CD45R(B220)CD25(TAC) expression was
analyzed by forward and side scatter gating (see insets) on large (C) and
on small cells (D). Percentages of double positive cells are summarized
in Table 1.
mutant strains of mice for total bone marrow. In the bone marrow
of 4 - 5 week old normal mice the percentages of
CD45R(B220)+/c-WT and CD45R(B220)+/CD43+ range from
3 to 5 and from 5 to 8% respectively. Thus, the
CD45R(B220)+/CD43+ population is 1.5-2 times larger than
the CD45R(B220)+/c->c/f+ population. Between 5 and 7% of the
bone marrow cells of these mice are large CD45R
(B220)+/CD25+ cells and between 15 and 20% are small
CD45R(B220)+/CD25+ cells.
In the bone marrow of age matched SCID, XsT, ^Ml and
RAG-2, the percentages of CD45R(B220)+/c-Wr+ and of
CD45R(B220)+/CD43+ cells are sfightly elevated when compared
with the percentages found in the bone marrow of normal mice
(see Table 1). In marked contrast, CD45R(B220)+/CD25+ large
as well as small cells in the bone marrow of these mutant mice
are below the FACS detection level. This indicates that both the
Xs protein and a membrane-bound n protein are required for the
formation of a CD45R(B220)+/CD25+ precursor B cell population.
To test this hypothesis RAG-2T mice which are rearrangement
incompetent but express normal levels of Xs (13,18) were
supplemented with a transgenic membrane-bound M chain.
Analysis of the bone marrow of these mice revealed a relatively
normal number of CD45R(B220)+/c-tof+ and CD45R(B220)+/
CD43+ cells when compared with normal inbred strains of
mice, but a 2- to 3-fold lower number when compared with normal
RAG-2T mice (Table 1). About 3 - 4 % of the bone marrow cells
of the RAG-2T mice expressing a transgenic membrane-bound
fi chain co-express CD45R(B220) and CD25, and are large, and
13-14% co-express these markers and are small. Thus, the
formation of a CD45R(B220)+/c-M+/CD43+ precursor B cell
compartment in the bone marrow is independent of rearrange-
ment and the expression of X5, while the formation of a
CD45R(B220)+/CD25+ compartment is dependent on the
expression of the X5 protein and a membrane-bound /» chain.
Expression of c-kit, CD43, CD25, BP-1, TdT, c/t and cXs protein
by CD45R(B220)+/c-kit+, CD45R(B220)+/CD43* and
CD45R(B220)*/CD25* precursor B cells of normal mouse bone
marrow
CD45R(B220)+ slgM- precursor B cells from bone marrow of
4 - 5 week old BALB/c mice were separated by preparative two-
Table 1 . Phenotypic stages of development of progenitor and precursor B cells in normal and mutant mouse bone marrow"
Mice
BALB/c
DBA/2
C3H/HeJ
CBA/J
C57BI/6
SCID
RAG-2T
RAG-2T + tgj<
Phenotypic markers
CD45R(B220)+
c-kit*
3.2
3.7
3.7
5.5
3.3
4.5
6.2
5.0
6.0
2.0
(percentage of nucleated
CD45R(B220)
CD43+
5.5
6.4
5.9
8.5
6.3
8.5
9.5
8.0
8.4
3.4
bone marrow cells)
CD45R(B220)+
CD25* (large)
6.7
5.7
5.9
5.4
5.0
0.1
0.5
0.2
0.6
3.5
CD45R(B220)+
CD25+ (small)
19.8
18.2
14.8
15.0
22.0
0.6
0.7
0.2
0.2
13.5
•The data are values derived from studies on the bone marrow of a pool of three or four 4 - 5 week old mice.
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Rg. 2. FACS analysis of cell surface expression of BP-1, CD25 and
COW on sorted CD45R(B220)+/c-fc/f\ of BP-1 CD25 and c-kit on
sorted CD45R(B220)+/CD43+ and BP-1 on sorted large CD45R
(B220)+/CD25+ bone marrow derived precursor B cells from 4 week
otd BALB/c mice. The percentages of positive cells are summarized in
Table 2.
color FACS into CD45R(B220)+/c-M + , CD45R(B220)+/CD43\
CD45R(B220)+/CD25+ large and CD45R(B220)+/CD25+ small
cells (Fig. 1). The separated cells were subsequently analyzed
for the expression of BP-1, CD25, c-kit and CD43 on the surface
(Fig. 2) as well as for the intraceBular expression of TdT, Xs protein
and 11H chains (Fig. 3). Table 2 summarizes the quantitation
of these analyses.
About half of the CD43+ precursor B cells express c-kit, while
none of the CD25+ precursors do. Almost all of the c-kit+
precursor B cells express CD43, while only 20% of the large and
practically none of the small CD25+ precursor B cells do. BP-1
expression in variable numbers was found on all subpopulations
of bone marrow derived precursor B cells. One third of the
CD45R(B220)+/CD43 + precursors do express CD25. TdT
expression was observed in the vast majority of c-kit+ precursors
and in about half of the CD43+ precursors. No TdT is detectable
in CD25+ precursor B cells. The 0X5 protein is detectable in the
vast majority of CD45R(B220)+/c-ttT and of CD45R(B220)+/
CD43+ cells. Only 25% of the CD25+ large precursor cells
Central Control Cental Control
TUT TdT TdT TdT
cX5
Fig. 3. FACS analysis of intracellular expression of TdT, Xj and p in
sorted CD45R(B220)+/c-/tf+ , CD45R(B220)+/CD43\ large CD45R
(B220)+/CD25+ and small CD45R(B220)+/CD25+ precursor B cells
derived from 4 week old BALB/c mice bone marrow. The percentages
are summarized in Table 2.
express X5 protein in the cytoplasm, while none of the CD25+
small precursors do. C/i expression is almost absent in CD45R
(B220)+/c-kit+ precursors, whereas one third of CD43+
precursors express c/i. The vast majority of CD25+ B cell
precursors express C/t. These analyses indicate that pre-B-l cells
are almost all CD45R(B220)+/c-M+/CD43+/CD25-/TdT+/
cX5+/c/»-. A part of them express BP-1.
Pre-B-ll cells can be divided into large and small. All pre-B-ll
cells are c-kit- /TdT- /CD25+7c/i+. About 20% of the large
pre-B-ll cells are CD43+, as well as cXs+, the other 80% are
CD43" and 0X5". Half of them express BP-1. Within the small
pre-B-ll cells practically all cells are CD43-/cXs-. A part of them
is BP-1 + . Thus, c-kit expression is restricted to pre-B-l cells,
whereas CD25 expression is restricted to pre-B-ll cells. Precursor
B cells that express CD43 consist of at least a mixture of pre-B-l
and pre-B-ll cells.
Cell cycle analysis of CD45R(B220)+Ic-kil*, CD45R(B220)+/
CD43+ and CD45R(B220)+/CD25+ precursor B cells of normal
mouse bone marrow
CD45R(B220)+ slgM" precursor B cells from bone marrow of
4 - 5 week old BALB/c mice were separated by preparative two-
color FACS into CD45R(B220)+/c-M + , CD45R(B220)+/CD43\
CD45R(B220)+/CD25+ large, and CD45R(B220)+/CD25+ small
cells (Fig. 1). From the separated cells nuclei were prepared and
their DNA content was analyzed as described in Methods. 01
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Table 2. Phenotype marker analysis of sorted populations of progenitor and precursor B cells of normal mouse bone marrow
Phenotypic marker Percentage of sorted
CD45R(B220)+
c-kit* cells
CD45R(B220)+
CD43+ cells
CD45R(B220)+
CD25+ (large) cells
CD45R(B220)+
CD25+ (small) cells
c-kit
CD43
BP-1
CD25
TdT
cx5
100
96
14
4
80
95
5
49
100
25
30
40
90
32
0.1"
20»
60
100
0.1
25
95
0.1
0.7
30
100
0.2
0.5
90
"These numbers are derived by calculation from staining done with CD45R(B220)+/c-tor+ and CD45R(B220)'lXD43+ sorting experiments (Rg. 2).
the CD45R(B220)+/c-Wf+ precursors 45% are in S and
phases of the cell cycle (Fig. 4A). Of the CD45R(B220)+/CD43+
population - 2 0 % is in S and Gj/M phase of the cell cycle (Fig.
4B), whereas - 7 0 % and < 5 % of large (Rg. 4C) respectively
small (Fig. 4D) cells of the CD45R(B220)+/CD25+ population
are in the S and G2/M phase of the cell cycle. Thus, CD45R
(B22O)+/c-tof+ pre-B-l cells and even more the CD45R(B220)+/
CD25+ large pre-B-ll cells are actively cycling while small
CD45R(B220)+/CD25+ pre-B-ll cells do not cycle. The marker
analyses described in the previous sections showed that
CD45R(B220)+/CD43+ precursors consist of at least a mixture
of pre-B-l cells and large pre-B-ll cells. The finding that far less
of the CD45R(B220)+/CD43+ cells are in S and G-./M phases
of the cell cycle than those of the pre-B-l compartment (20 versus
45%) and those of the large pre-B-ll compartment (20 versus
70%) indirectly indicates that the CD45R(B220)+/CD43+
compartment must contain a third population of cells which does
not cycle. The possible nature of this third population will
be discussed below.
Discussion
We have analyzed the precursor B cell compartments of normal
and mutant mouse bone marrow. The results which are summarized
in Table 1 are derived from analysis performed on 4 - 5 week
old mice. Here it is important to note that with age, although the
relative ratios between the different subpopulations stay constant
their absolute numbers decrease (23).
Previous work by Osmond etal. (1,28,29), Hardy etal. (2,5),
Nishikawa etal. (4), Rajewsky etal. (19-21,30,31) and ourselves
(14,24,32) has defined subpopulattons of cells in the development
of mature B cells from pluripotent stem cells and B-lineage-
committed progenitors in mouse bone marrow. In this paper we
add the analysis of the expression of the IL-2 receptor o chain
(CD25.TAC) on the surface of defined stages of B eel development
It is a useful marker to distinguish pre-B-l from pre-B-ll cells. Figure
5 shows a model of B cell development in mouse bone marrow
based on our analyses, and Table 3 correlates this model and
the corresponding nomenclature to those used by different
laboratories. Generally, the different subpopulations can be
correlated well with each other. Only a few discrepancies
and uncertainties remain.
Osmond 's late pro-B cells and large pre-B cells, defined as
Cfi~ and cn+ CD45R(B220)+/ slgM~, TdT" respectively is one
example of a discrepancy. Osmond's late pro-B cells are different
DMA content
Fig. 4. DNA content analysts in nuclei prepared from sorted CD45R
(B220)+/c-*/r + (A), CD45R(B220)+/CD43+ (B), large CD45R(B220)+/
CD25+ (C) and small CD45R(B220)+/CD25+ (D) precursor B cells
derived from slgM depleted bone marrow of 4 week old BALB/c mice.
The marker indicates the percentage of cells in S and Gj/M phases of
the cell cycle. These percentages of cells in S and Gj/M phases are A,
45%; B, 20%; C, 70%; D, 3%.
from our large pre-B-ll cells, since the latter are >85% C/»+
(Table 2). It might well be possible that Osmond's c>r late pro-B
cells, detected in situ in bone marrow sections, are out-of-frame
rearranged large pre-B-ll cells (Fig. 5), which are on their way
to die by apoptosis. By the time we have taken them out of bone
marrow, stained them as single cell suspensions and analyzed
them by FACS, they might already be dead. Alternatively, the
level of expression of n in the cytoplasm might differ in the two
populations, so that by in situ fluorescence analyses under the
microscope half of the cells might score as negative, while FACS
detects them as positive.
Another area of uncertain correlations is the transition from
Hardy's pro-B to pre-B cells, i.e. the transitions from fractions
B to C, to C, to D. Both Hardy's (5) and Rajewsky's (21)
laboratories find cells with V^D^-rearranged H chain gene loci
in fractions C, C and D, while practically all of our pre-B-l cells
are DJH-rearranged and the vast majority of pre-B-ll cells have
undergone productive VHDJH rearrangement. The transition
from pre-B-l to large, and later small pre-B-ll cells is most
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Table 3. B lymphopoiesis in mouse bone marrow (correlation and comparison of nomenclature used in different laboratories)
Nomenclature
This paper
Osmond era/.
Nishlkawa et at.
Hardy etal.
pro-B
earty pro-B
B-pro-l
PA6 only
Fraction A
pre/pro-B
pre-B-l
intermediate pro-B
B-pro-ll
PA6-IL-7
fractions B, C
early late
pro-B pro-B
large pre-B-l I
late pro-B
large pre-B
small pre-B-ll
small pre-B
CFU - IL-7
IL-7 only
D
pre-B
immature B
immature B
immature B
mature B
mature B
mature B
o
CD2S(TAC)?
•ctive cyding cells
c-kB
CO43"
XS'/VpnB
TdT
COM (TAC)-
proB / preB I large preB I
oa
•igD
mature B
Rg. 5. A model of B cell development in normal mouse bone marrow based on the analysis described in this paper. This model describes the
phenotypes of the vast majority of all B lineage cells in bone marrow. We expect minor populations to express other phenotypes in transition from
one to another major compartment, and cannot rule out other, minor pathways of B cell development. Large circles, active cycling cells; small circles,
resting cells; 'irregular' circles, cells bound to die.
clearly defined by the change of expression of c-kit from positive
to negative, of TdT from positive to negative and of CD25 from
negative to positive. It underlines the usefulness of CD25 since
it is so far the only surface marker which is upregulated during
this transition.
Approximately twice as many CD45R(B220)+ cells express
CD43 than do c-kit (Table 1). Practically all the c-kit* cells
appear to co-express CD43 (Table 2) and most of them are
cycling. Some of the remaining CD43+, c-kit - cells are large,
cycling cells and express cp, 0X5 and CD25, but not TdT. They
are expected to be a subpopulation of large pre-B-ll cells in transit
from pre-B-l to small pre-B-ll cells. However, the relationship of
pre-B-l to large pre-B-ll cells, which are either CD43+ or CD43",
to small pre-B-ll cells has to be investigated in future experiments.
CD43 appears to be down-regulated later than c-kit and TdT,
and also later than CD25 is up-regulated, and maybe at the same
time as the expression of surrogate L chain is down-regulated.
Another part of the CD43 + , c-kit ~ population appears to be
less actively cycling and is c/t". They might be pre-B-ll cells with
non-productively VHDJH rearranged H chain gene loci on their
way to apoptosis (Fig. 5). Alternatively, they could be pro-B cells
before the expression of c-kit and TdT, maybe related to fraction
A of Hardy etal. (2,5). In the latter case, they should have all
their H chain gene loci in germline cofiguration. Future
experiments are aimed at testing this.
While CD25 on the surface of pre-B-ll cells is a useful marker
to distinguish them from pre-B-l cells and from immature B cells,
its function in B cell development at these early stages remains
unknown. IL-2 has no effect on either proliferation or differentiation
of pre-B cells in tissue culture (unpublished observations).
Moreover, mice with a targeted deletion of the IL-2 gene have
no obvious B cell deficiency (33). Therefore it remains to be
investigated whether the other, i.e. the 0 and 7 chains, of
the IL-2 receptor are expressed at this earty stage or whether
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the o chain is connected to other polypeptides, possibly
with other functions.
B lineage committed, CD45R(B220)+ precursor B cells in
RAG-2T, /iMT, X5T and SCID mice lack CD25+ cells almost
completely, while they are present in almost normal numbers in
RAG-2T mice expressing a transgenic /iH chain gene under the
control of the heavy chain enhancer (E^) (Table 1). This indicates
that the expression of the pH chain and surrogate L chain in
membranes (and probably on the surface) of precursor B cells
allows their entry into the pre-B-ll compartments and their
proliferative expansion. Since the composition of cells at the
transition point from pre-B-l to large pre-B-ll cefe is indistinguishable
in RAG-2T, SCID, MMT and X J mice, and since no large CD25*
cells can be found in the bone marrow of any of these mutant
mice the block in the differentiation appears to be at the same
stage of B cell development for all these mutants.
Pre-B-l cells express surrogate L chain together with a complex
of polypeptides (p130, p65) on their surface (13), while large,
cycling c-Wr, CD43+ pre-B-ll cells co-express the /iH chain
and surrogate L chain, and are likely to assemble them in an
Ig-like complex, in membranes, probably on the surface. The role
of the complex of p130/p65 with the surrogate L chain is unclear.
One possible role could be to signal pre-B-l cells to enter the
large pre-B-ll compartment, while the complex of /tH chain with
surrogate L chain in or on the large pre-B-ll cells might signal
the cells to expand by proliferation. Such a scenario would have
predicted that SCID, RAG-2T and tiMl mice should have some
CD25+ large pre-B-ll cells (since they are potentially capable of
expressing the p150/p65 surrogate L chain complex) while X5T
mice would not (since they cannot express this early complex
of proteins on the surface). This, however, appears not to be the
case, since bone marrow of all these mutant mice lack practically
all of the CD25+ large pre-B-ll cells. Consequently, the only role
of surrogate L chain in B cell development identified so far is
to expand by proliferation those pre-B-ll cells which express
membrane-bound pH chains.
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